Skip to content

Clinical trials

Completed Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Status: Completed Clear all

345 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20005
20013
200214
200319
20044
200520
200617
200714
200825
200927
201017
201115
201221
201311
201412
201512
201613
201714
201810
201914
202017
202114
202210
20237
20244

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed345

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer16
Novartis Pharmaceuticals15
Eli Lilly and Company9
Amgen8
H. Lee Moffitt Cancer Center and Research Institute7
National Cancer Institute (NCI)7
AstraZeneca6
Akamis Bio5
Bayer5
Steba Biotech S.A.5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma345
Neoplasms114
Carcinoma, Non-Small-Cell Lung54
Neoplasm Metastasis47
Lung Neoplasms31
Adenocarcinoma30
Pancreatic Neoplasms22
Carcinoma, Hepatocellular21
Breast Neoplasms20
Neoplasms by Site20

Trials

Showing 76 to 100 of 345. Each trial links to its page on Pharma Observatory.

245 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.